Skip to content

Insider · CIK 0001725929

Kinnari Patel

officer

Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Nov 25, 2024, latest May 22, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 3
$99k bought, $74k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RCKT: ROCKET PHARMACEUTICALS, INC.

RCKTOct 9, 2026 · close 2.56

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$4,944
767 shares
-0%+43% from low-69% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$9,198
1,409 shares
-0%+36% from low-70% from high
51Moderate
RCKTbuy 2
ROCKET PHARMACEUTICALS, INC.
$99k
21,099 shares
+372%+13% from low-75% from high
37Weak
RCKTsell 4
ROCKET PHARMACEUTICALS, INC.
$60k
4,588 shares
-1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 20, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-767$6.45$4,944441,927May 22, 2025
May 16, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,409$6.53$9,198442,694May 20, 2025
Apr 9, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
POpen-market purchase
Common Stockindirect: By Spouse
+21,099$4.70$99k26,774Apr 10, 2025
Nov 21, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-4,588$13.05$60k392,395Nov 25, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kinnari Patel: insider trades and track record | InsiderTell